Introduction {#s1}
============

Mitochondria host a number of biosynthetic pathways and produce most of the cell's ATP through oxidative phosphorylation, which is carried out by the electron transport chain (ETC) complexes located on the mitochondrial inner membrane. While the majority of mitochondrial proteins are encoded on the nuclear genome, synthesized in the cytoplasm, and imported into the mitochondria, a subset of core ETC components are encoded on the mitochondrial genome (mtDNA) and synthesized inside the mitochondrial matrix. Thus, mitochondria biogenesis and ETC activity in particular, rely on the coordinated expression of both nuclear- and mtDNA-encoded mitochondrial genes ([@bib16]). Mitochondria vary in number and activity to meet the different energy and metabolic demands of different tissues and developmental processes. Mitochondria are transmitted exclusively through the maternal lineage in most metazoans ([@bib68]), which demands a complex regulation of mitochondrial biogenesis and ETC activity during oogenesis. Animal oocytes are hundreds of times larger than their progenitors ([@bib50]). During this tremendous oocyte growth, mitochondria undergo prodigious biogenesis and increase mtDNA copy number over a thousand folds ([@bib61]). The massive amount of mitochondria in the mature oocyte is necessary to power early embryonic development, as inadequate mitochondrial contents often lead to embryonic lethality ([@bib37]). However, the mechanism by which the germline couples mitochondrial biogenesis to oocyte development remains elusive.

While furnishing mature oocytes with sufficient number of mitochondria, oogenesis also limits the transmission of harmful mtDNA mutations. The mitochondrial genome is prone to accumulating mutations because of its close vicinity to the highly mutagenic free radicals present in the mitochondrial matrix and of a lack of effective repair mechanisms ([@bib48]). Yet, harmful mtDNA mutations are rare in populations ([@bib62]), underscoring the presence of efficient mechanisms to limit their transmission through the female germline. We previously reported that mtDNA replication depends on active respiration in the *Drosophila* ovary ([@bib24]). Healthy mitochondria with wild-type genomes propagate more vigorously than defective ones carrying harmful mutations, thereby curbing the transmission of deleterious mtDNA mutations to the next generation ([@bib73]). Therefore, an active ETC appears to be a stress test for the functionality of mtDNA, and is essential for mtDNA selective inheritance. Nonetheless, how the activity of the ETC is regulated during oogenesis is not well understood.

Insulin signaling (IIS), an evolutionary conserved pathway that controls cell growth and proliferation ([@bib42]), has also been shown to regulate ETC biogenesis and ATP production in human skeletal muscles ([@bib64]). In the *Drosophila* ovary, IIS promotes the growth of follicles from the early to the middle stages of oogenesis ([@bib32]). IIS activity decreases before the nurse cells dump their content into the oocyte. This decrease relieves the inhibition of GSK3, thereby shutting down mitochondrial respiration ([@bib58]). However, oogenesis begins with germline stem cells (GSCs) that are thought not to rely on oxidative phosphorylation to ATP production ([@bib29]). We predicted there had to be developmental cues to activate mitochondrial respiration in the late germarium stage when mtDNA replication commences. IIS represents a logical candidate to modulate this metabolic transition in early oogenesis. Nonetheless, it remains to be explored how IIS is dynamically regulated during oogenesis and whether it is indeed involved in the aforementioned metabolic transition. Furthermore, little is known regarding how IIS modulates ETC activity and mtDNA biogenesis in general.

In this study, we find that mitochondrial respiration is quiescent in GSCs and dividing cysts, but markedly upregulated in the late germarium, the same spatial-temporal pattern as mtDNA replication. We uncover a feedforward loop between IIS and Myc protein which orchestrates the transcriptional activation of respiration and mtDNA replication. Furthermore, transient JNK activity boosts insulin receptor (InR) transcription to enhance the IIS-Myc loop. Our work uncovers how developmental programs couple mitochondrial biogenesis with cell growth and mitochondrial inheritance.

Results {#s2}
=======

Coordinated transcription of both nuclear and mitochondrial genome controls etc biogenesis {#s2-1}
------------------------------------------------------------------------------------------

Mitochondrial DNA replication is significantly increased in the post-mitotic germ cells in late germarium and relies on the mitochondrial inner membrane potential (ψ~m~) and etc activity ([@bib24]). We therefore hypothesized that mitochondrial respiration might be developmentally regulated in a spatio-temporal pattern similar to that of mtdna replication. To test this idea, we monitored ψ~m~, which is an indicator of mitochondrial respiration, in the developing germ cells. We found that ψ~m~, measured as the ratio of tmrm (an indicator of membrane potential) to mitotracker green (an indicator of mitochondrial mass) ([@bib73]), was markedly higher in region 2b than at earlier stages in the germarium ([Figure 1A](#fig1){ref-type="fig"}), indicating that respiration is activated in the 16-cell cysts, concomitantly with the onset of mtdna replication. Consistently, etc activity, indicated by a dual sdh (succinate dehydrogenase)/cox (cytochrome c oxidase) colorimetric assay ([@bib55]), was much higher in region 2b than at earlier germarium stages and remained high until the stage-10 egg chamber ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). These results suggest that etc activity is upregulated in the late germarium stages.

![ETC activity and gene expression sharply increase at germarium stage 2B.\
(**A**) Upper panel: a representative image of a germarium stained with TMRM (a membrane potential marker) and MitoTracker Green (a mitochondrial mass marker). Germarium regions are indicated. Arrows indicate mitochondria in germ cells (GCs). Lower panel: TMRM/MitoTracker Green ratiometric image, indicating that mitochondria membrane potential in stem cells and dividing cysts is low, but markedly increased in 16-cell cysts and budding egg chambers. Scale bar, 5 μm. (**B**) Upper panel: a representative image of a wt ovariole (from germarium to stage nine egg chamber) stained for the COX/SDH dual activities. Lower panel: a representative high-magnification image of a germarium stained for COX/SDH. Note the onset of COX/SDH activity in region 2B of the germarium (arrowhead). Scale bars, 50 μm for the upper panel and 10 μm for the lower panel. (**C**) Visualization of the *CoxIV* and *CoxIII* mRNAs in germaria from wt flies by FISH with fluorescently labeled DNA probes. Germaria are outlined with dotted lines. For each mRNA labeling, lower panels illustrate the enlarged areas of germarium region 2A (red dotted line) and 2B (green dotted line), respectively, shown in the upper panels. Scale bars, 5 μm. (**D**) Quantification of the relative expression level of *CoxIV* or *CoxIII* mRNA in different regions of germarium. Note that both transcripts are markedly induced in region 2B germarium. Error bars represent SEM. (**E**) RNAi screen for genes required to induce ETC activity in germaria. For each RNAi line, the impact on ETC activity is scored as the percentage of germaria with reduced COX/SDH staining.\
10.7554/eLife.49309.004Figure 1---source data 1.Ratio of mRNA in region 2B and region 2A of the germarium.](elife-49309-fig1){#fig1}

We next asked whether the dynamic pattern of ETC activity in the germarium reflected the expression of ETC subunits. Except for complex II (SDH) components, which are encoded on nuclear genome only, all other ETC proteins are encoded by both nuclear and mitochondrial genomes. Thus, we performed fluorescence in situ hybridization (FISH) with fluorescently labeled DNA probes specific to mRNAs of either nuDNA- or mtDNA-encoded ETC subunits in ovaries. Both COXIV (nuclear-encoded) and COXIII (mtDNA-encoded) transcripts exhibited low expression in earlier regions, but increased 4 to 6 folds in region 2B, recapitulating the pattern of ETC activity ([Figure 1C,D](#fig1){ref-type="fig"}). The same pattern was observed for Cyt-C1 (nuclear-encoded) and Cyt-B (mtDNA-encoded) ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). These results indicate that the increased ETC activity detected with our COX/SDH colorimetric assay correlates with an increase of ETC genes expression at region 2B germarium. Taken together, these data suggest that the activation of respiration at stage 2B may partially relies on the coordinated transcription of nuDNA- and mtDNA-encoded genes.

A candidate RNAi screen for upstream regulators of ETC biogenesis {#s2-2}
-----------------------------------------------------------------

To uncover the developmental cues that initiate ETC gene transcription in the late germarium, we screened a collection of 132 RNAi lines directed at major developmental pathways and at factors involved in cellular metabolism and mitochondrial functions ([@bib4]; [@bib10]; [@bib14]; [@bib47]). We expressed dsRNAs to knockdown genes in the germ cells using a *nanos*-Gal4 (*nos*-Gla4) driver and applied the COX/SDH dual activity assay as an indirect measure of ETC abundance ([@bib55]) ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). We also included a few RNAi lines directed at COX components or genes essential for mitochondrial biogenesis as positive controls. As expected, knocking down these genes consistently impaired ETC activity ([Figure 1E](#fig1){ref-type="fig"}). Overall, 6 RNAi lines from the list caused germline degeneration and 12 lines led to reduced ETC activity without causing the loss of the germline or other defects in development. Among these 12 lines are components of the IIS/TORC1 signaling, the JNK pathway, cell adhesion molecules, translation regulators and one transcription factor ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Notably, all hits impaired activities of both COX and SDH, except for *coxV* RNAi, which disrupted COX activity only, indicating that the recovered genes are required for the expression of both nuclear and mitochondrial genes.

Myc controls ETC biogenesis and mtDNA replication {#s2-3}
-------------------------------------------------

The transcription factor Myc emerged as one of the strongest hits from our screen. Myc has been demonstrated to boost mitochondrial biogenesis and regulate energy metabolism in mammals ([@bib1]; [@bib12]; [@bib26]; [@bib33]). Additionally, we found that Myc's expression pattern, monitored with a Myc-GFP fusion protein ([@bib22]), mirrored the pattern of ETC activity in the ovary: low in the early stages, but elevated in germarium region 2B and remaining high until mid-stage egg chambers ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). These observations spurred us to explore the potential roles of Myc in the induction of ETC activity in region 2B cysts. To confirm the result of the Myc RNAi from the screen, we utilized a hypomorphic Myc allele, *myc^P0^*, which has reduced level of *myc* mRNA, but progresses through early oogenesis ([@bib27]; [@bib52]). To get a semi-quantitative measure of COX activity, we visualized COX activity in the ovary ([Figure 2---figure supplement 2A,B](#fig2s2){ref-type="fig"}). Then, we generated a standard enzymatic activity curve for COX ([Figure 2---figure supplement 2C,D](#fig2s2){ref-type="fig"}) adopting previously established procedures ([@bib28]; [@bib38]). The activity of COX in the germarium was normalized to the COX activity on the standard curve. Consistent with the RNAi result, COX activity was markedly reduced in the *myc^P0^* ovaries, and mtDNA replication was also reduced ([Figure 2B--E](#fig2){ref-type="fig"}). Next, to test whether Myc is sufficient for ETC activity induction, we over-expressed *myc* ORF with a *bam*-Gal4 in the dividing cysts in region 2A that normally have low levels of COX activity and Myc protein. Over-expression of Myc in this region ectopically enhanced COX activity ([Figure 2B,C](#fig2){ref-type="fig"}). Thus, Myc is both necessary and sufficient to stimulate mitochondrial respiration in the ovary.

![A candidate RNAi screen reveals Myc as an essential regulator of mitochondrial biogenesis.\
(**A**) Left panel: germarium of a fly endogenously expressing Myc-GFP stained with anti-GFP (Green) and anti-1B1 (Red). Right panel: germarium of a fly expressing LacZ driven by the *myc* endogenous promoter stained with anti-β-galactosidase (Green) and anti-1B1 (Red). Myc protein is expressed at low level in GSCs and dividing cysts, but markedly induced from region 2B germ cells. In contrast, *myc* promoter activity is uniform in the germarium. Scale bars, 10 μm. (**B**) COX activity in germaria from wt, *myc^P0^*, *bam* \>*ctrl*, and *bam* \>*myc^OE^* ovaries visualized by COX single staining. The activities are normalized to that of region 2B cysts wt. COX activity is significantly reduced in the *myc^P0^* mutant, but is ectopically induced when Myc is over-expressed in region 2A by *bam*-Gal4. Scale bars, 10 μm. (**C**) Quantifications of relative COX activity in germarium regions from wt, *myc^P0^*, *bam* \>*ctrl*, and *bam* \>*myc^OE^* flies. ETC activities is normalized to that in the wt 2B cysts. n = 10 germaria for each genotype. Error bars represent SEM. \*p\<0.05. (**D**) Visualization of mtDNA replication in germaria from wt and *myc^P0^* ovaries with EdU incorporation (Green) and co-staining with anti-1B1 (Red). Arrowheads point to EdU incorporation into mtDNA, while arrows point to EdU incorporation into the nuclear genome. Scale bars, 10 μm. (**E**) Area of EdU puncta (pixels) normalized to total pixels at indicated germarium stages in the germline cysts from wt and *myc^P0^* ovaries. n = 11 cysts for each column. Error bars represent SEM. \*p\<0.005. (**F**) Table of genes functioning in mitochondrial processes with at least 3-fold decreased expression in *myc^P0^* ovaries compared with wt ovaries. (**G**) Diagrams of decreased genes encoding mitochondrial processes and transcription factors (TFs) in the *myc^P0^* ovaries. A number of genes in either category has a Myc binding site in their regulatory region.\
10.7554/eLife.49309.008Figure 2---source data 1.Relative ETC activity and mtDNA area in the germarium regions.](elife-49309-fig2){#fig2}

To gain insight into how Myc regulates mitochondrial biogenesis, we compared the transcriptomes of wt and *myc^P0^* mutant ovaries ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). RNA sequencing (RNAseq) showed that nearly one-third of the detected transcripts were reduced in *myc^P0^* mutant compared to wt (fold change \>3.0, FDR \< 0.05%) ([Figure 2F](#fig2){ref-type="fig"}), consistent with the notion of Myc as a general transcription activator ([@bib43]). We found that the downregulated genes were enriched in nuclear-encoded mitochondrial genes ([@bib73]). About 52% of the total mitochondrial genes, and 75% of ETC genes and factors for mtDNA replication and expression were downregulated ([Figure 2F](#fig2){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}, and [Supplementary file 4](#supp4){ref-type="supplementary-material"}). Myc directly regulates the expression of its targets by binding to a short sequence, CACGTG (E-box) in the regulatory region ([@bib31]). Interestingly, 421 out of 458 down-regulated mitochondrial genes have predicted Myc binding sites in their regulatory regions, further substantiating a role for Myc in promoting mitochondrial biogenesis by boosting the transcription of mitochondrial genes ([Figure 2G](#fig2){ref-type="fig"} and [Supplementary file 4](#supp4){ref-type="supplementary-material"}). Additionally, 45 transcriptional factors, 33 of which have E-boxes in their regulatory regions, were also decreased in *myc^P0^* mutant ovaries ([Figure 2F,G](#fig2){ref-type="fig"} and [Supplementary file 5](#supp5){ref-type="supplementary-material"}), suggesting that secondary transcriptional controls might also be involved in Myc's regulation of mitochondrial biogenesis.

IIS regulates Myc post-transcriptionally through Sgg and Thor {#s2-4}
-------------------------------------------------------------

Having identified Myc as the master regulator of ETC biogenesis and mtDNA replication in the ovary, we sought to explore how the spatio-temporal pattern of Myc protein was established. Myc can be regulated either transcriptionally or post-transcriptionally by a variety of upstream signals ([@bib17]). We first examined *myc* transcription by visualizing its promoter activity using a *myc-LacZ* transgene ([@bib40]). In contrast to Myc protein, which was markedly upregulated at region 2B, *myc* promoter activity appeared to be uniform in the germarium ([Figure 2A](#fig2){ref-type="fig"}), suggesting that post-transcriptional regulations are responsible for the spatial pattern of Myc protein. IIS/TORC1 signaling is known to regulate both translation and protein stability ([@bib19]; [@bib36]; [@bib45]), and multiple genes in the IIS/TORC1 signaling emerged from the initial RNAi screen. Consistently, COX activity and mtDNA replication were markedly impaired in ovaries of *chico* mutant flies ([Figure 3A--C](#fig3){ref-type="fig"}), which were obtained by combining two *chico* mutant alleles, *chico^1^* (loss of function) and *chico^KG^* (hypomorphic) ([@bib5]; [@bib60]). These data support a critical role of IIS in ETC biogenesis and mtDNA replication. Intriguingly, the activity of IIS, revealed by staining for phosphorylated AKT at serine 505 (p-AKT) ([@bib46]), was also increased in the germarium region 2B and maintained until mid-stage egg chambers ([Figure 3D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), a pattern similar to that of Myc protein. In contrast, total AKT staining was uniform in the germarium ([Figure 3D](#fig3){ref-type="fig"}). These observations suggest that Myc may be regulated by IIS. Indeed, Myc protein was strongly reduced in *chico^1^*^/*KG*^ mutant ovaries ([Figure 3E,F](#fig3){ref-type="fig"}). In *chico* RNAi ovaries, Myc protein was also diminished in germ cells, while the expression of *myc-LacZ* was not affected ([Figure 4B](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Importantly, over-expressing Myc in the *chico* RNAi background restored ETC biogenesis in the ovary ([Figure 4D](#fig4){ref-type="fig"}). Altogether, these results suggest that upregulation of IIS in late germarium stimulates ETC biogenesis and mtDNA replication through post-transcriptional control of Myc level.

![Elevated IIS in late germarium induces Myc protein to prime mtDNA replication and mitochondrial respiration.\
(**A**) Representative germaria from wt or *chico^1^*^/*KG*^ mutant flies incorporating EdU and stained with anti-1B1. Arrowheads indicate EdU incorporation into the mtDNA of germ cells. Scale bars, 10 μm. (**B**) Quantification of the mitochondrial EdU puncta areas relative to the areas of germline cysts from wt or *chico^1^*^/*KG*^ mutant flies. n = 11 cysts each column (left to right). Error bars represent SEM. \*p\<0.005. (**C**) Quantifications of COX activity in region 2B cysts from wt or *chico^1^*^/*KG*^ mutant flies. The activities are normalized to that of region 2B cysts from wt. n = 10 germaria for each genotype. Error bars represent SEM. \*p\<0.005. (**D**) Germaria from wt ovaries stained with anti-AKT and anti-p-AKT (S505). p-AKT staining is low in both GSCs and dividing cysts, while increased from region 2B germ cells. In contrast, AKT staining is uniform in the germarium. Scale bars, 10 μm. (**E**) Germaria from wt or *chico^1/KG^* mutant ovaries endogenously expressing Myc-GFP stained with anti-GFP, anti-1B1, and DAPI. Scale bars, 10 μm. (**F**) Quantification of relative Myc-GFP intensity in germarium region 2B from wt or *chico^1/KG^* mutant ovaries. n = 10 germaria for each genotype. Error bars represent SEM. \*p\<0.005.\
10.7554/eLife.49309.011Figure 3---source data 1.Relative mtDNA area, COX activity and Myc-GFP intensity in the germarium.](elife-49309-fig3){#fig3}

![IIS promotes ETC activity via inhibition of GSK3 to stabilize Myc.\
(**A**) Schematic of the conserved IIS pathway that inhibits 4E-BP/Thor and GSK3/Sgg to promote protein translation and suppress protein degradation, respectively. (**B**) Germaria from ovaries of *ctrl; chico^RNAi^; chico^RNAi^*, *thor^RNAi^*; and *chico^RNAi^*, *sgg^RNAi^* driven by *nos*-Gal4 endogenously expressing Myc-GFP and stained with anti-GFP (green) and anti-1B1 (red). Scale bars, 5 μm. (**C, D**) Quantification of Myc-GFP intensity (**C**) and COX activity (**D**) in germarium region 2B from ovaries with indicated genotypes, normalized to the intensity or activity values in germaria with *ctrl* over-expression. (**C**) n = 10 germaria for each genotype. (**D**) n = 10 germaria for each genotype. Error bars represent SEM. \*p\<0.05. (**E**) Germaria from ovaries of *ctrl* and *sgg^RNAi^* driven by *nos*-Gal4 endogenously expressing Myc-GFP and stained with anti-GFP and anti-1B1. Myc protein is up-regulated in both region 2A and region 2B germ cells in the *sgg* RNAi ovary. Scale bars, 10 μm. (**F**) Quantification of relative Myc-GFP intensity in germarium region 2B from ovaries of *ctrl* and *sgg^RNAi^* driven by *nos*-Gal4. Myc-GFP intensity is normalized to that of region 2B cysts with *ctrl* expression. n = 7 germaria for each genotype. Error bars represent SEM. \*p\<0.01. (**G**) A germarium from wt flies stained with anti-GSK3 and anti-p-GSK3. Germaria are outlined with dotted lines. Scale bars, 5 μm. (**H**) Upper panel: a representative image of a germarium from ovaries expressing endogenous InR-EGFP. Lower panel: visualization of the *InR* mRNA in germarium by FISH with fluorescently labeled DNA probes. Germaria are outlined with dotted lines. Scale bars, 5 μm.\
10.7554/eLife.49309.014Figure 4---source data 1.Relative COX activity and Myc-GFP intensity in the germarium.](elife-49309-fig4){#fig4}

Next, we explored how IIS regulates Myc. IIS either promotes protein translation by repressing 4E-BP/Thor, or stabilizes its targets by antagonizing GSK3/Sgg-dependent protein degradation ([Figure 4A](#fig4){ref-type="fig"}) ([@bib19]; [@bib36]; [@bib45]). Knocking down *sgg* in a *chico* RNAi background restored Myc protein level and COX activity, while *thor* RNAi only partially rescued both ([Figure 4B--D](#fig4){ref-type="fig"}). Intriguingly, *sgg* RNAi not only elevated Myc protein level in region 2B and thereafter, but also strongly induced Myc in earlier stages where Myc protein is not normally present ([Figure 4E,F](#fig4){ref-type="fig"}). Next, we examined the pattern of GSK3 and GSK3 activity in the germarium. GSK3 activity is suppressed by IIS through AKT-mediated phosphorylation on GSK3 serine 9. GSK3 protein visualized by both antibody staining and an endogenous expressed Sgg-GFP was ubiquitous in the germarium ([Figure 4G](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). However, phosphorylated GSK3 ([Figure 4G](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), the inactive form of GSK3, became evident in region 2B germarium and later stages egg chambers, the same pattern as ETC biogenesis ([Figure 1B,C](#fig1){ref-type="fig"}), Myc ([Figure 2B](#fig2){ref-type="fig"} and [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), and p-AKT ([Figure 3D](#fig3){ref-type="fig"}). Taken together, these data suggest that Sgg is the main regulator of Myc and acts downstream of IIS.

InR expression is boosted at region 2B germarium {#s2-5}
------------------------------------------------

So far, our data has established Myc as the link between IIS, a major pathway regulating cell proliferation and growth, and mitochondrial biogenesis in ovaries. The IIS regulates germ cells growth and proliferation in response to insulin-like peptides (dilps) produced by neuroendocrine cells ([@bib32]). *Drosophila* has an open circulatory system. In a given tissue, all cells are exposed to a similar level of dilps circulating in the hemolymph. However, instead of being uniform in the germarium, the activity of IIS, indicated by both p-AKT and inhibitory phosphorylated Sgg staining ([Figures 3D](#fig3){ref-type="fig"} and [4G](#fig4){ref-type="fig"}), demonstrated a distinct spatio-temporal pattern similar to that of Myc, ETC expression and mtDNA replication. Therefore, some IIS components downstream of dilps must be differentially expressed in the germarium.

To test this idea, we generated an InR-EGFP reporter line by inserting an EGFP at the C-terminus of the *InR* genomic locus. Using this line and other reporter lines ([@bib39]; [@bib44]; [@bib56]), we examined the expression patterns of InR and other components of IIS signaling upstream of AKT. InR-EGFP was upregulated in region 2B ([Figure 4H](#fig4){ref-type="fig"}), while all other components in the IIS signaling examined were ubiquitously expressed in the germarium ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Additionally, *InR* mRNA, visualized by FISH, demonstrated the same pattern as that of InR-EGFP ([Figure 4H](#fig4){ref-type="fig"}), suggesting that upregulation of *InR* transcription enhances IIS to boost mitochondrial biogenesis.

Both JNK pathway and Myc promote IIS via *InR* transcription {#s2-6}
------------------------------------------------------------

We next asked how *InR* transcription was elevated at region 2B germarium. The JNK pathway, which transcriptionally controls various cellular processes ([@bib70]), had emerged from the initial RNAi screen. Consistent with the RNAi screen, homozygous *bsk^1^* clones showed impaired mtDNA replication, compared to *bsk^1^*/*+* heterozygous germ cells ([Figure 5A,B](#fig5){ref-type="fig"}). Interestingly, JNK signaling activity, visualized by a *puc-LacZ* reporter ([@bib35]), was sharply up-regulated in late germarium stages, but decreased and eventually disappeared in growing egg chambers ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). The partial overlap between the spatial patterns of IIS and JNK activation, and the phenotypic resemblance between IIS and JNK mutations on COX activity and mtDNA replication, suggested a potential link between these two pathways. Indeed, IIS activity, Myc protein, InR-EGFP, and *InR* mRNA were all markedly reduced in ovaries expressing dsRNA against either *bsk* or *jra*, fly homolog of JNK or Jun, respectively ([Figure 5D--H](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C--G](#fig5s1){ref-type="fig"}). In *bsk* RNAi or *jra* RNAi background, over-expression of *InR* restored Myc level and over-expression of either *InR* or *Myc* rescued COX activity ([Figure 5H,I](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1G](#fig5s1){ref-type="fig"}). In contrast, enhancing JNK signaling by *puc* RNAi failed to rescue defective ETC activity in a *chico* RNAi background ([Figure 5I](#fig5){ref-type="fig"}). Together, these observations suggest that JNK promotes mitochondrial biogenesis respiration and mtDNA replication in late germarium stages by boosting IIS.

![Transient JNK activation in the germarium boosts the IIS-Myc signaling.\
(**A**) Representative germaria with *bsk^1^* FRT clones showing EdU incorporation (green) to visualize mtDNA replication. *bsk^1^/+* cells are positive for mRFP (red), while *bsk^1^* mutant cells are negative for mRFP. Arrows indicate EdU incorporated into mtDNA, arrowheads point out EdU incorporated into the nuclear genome. Scale bars, 5 μm. (**B**) Percentage areas of EdU incorporated into mtDNA relative to total areas of the germline cysts at indicated germarium stages from *bsk^1^/+* and *bsk^1^* clones. n = 11, 14, 15, and 10 cysts each column (left to right). Error bars represent SEM. \*p\<0.005. (**C**) Germarium from ovaries expressing *LacZ* driven by the *puc* promoter stained with anti-β-galactosidase (green) and anti-Vasa (red). Germarium is outlined with dotted lines. Scale bar, 10 μm. (**D**) Germaria from ovaries of *ctrl* and *bsk^RNAi^* driven by *nos*-Gal4 stained with anti-p-AKT (green) and anti-1B1 (red). Note that IIS activity is markedly reduced when JNK signaling is decreased by *bsk* RNAi. Scale bars, 10 μm. (**E**) Quantification of p-AKT intensity from cysts in germarium region 2A and 2B of ovaries with indicated genotypes. p-AKT intensity is normalized to that of region 2B cysts from the *ctrl* line. n = 11 germaria for each genotype. Error bars represent SEM. \*p\<0.005. (**F**) Visualization of InR-EGFP in germaria from ovaries of *ctrl* and *bsk^RNAi^* driven by *nos*-Gal4. Note that InR-EGFP level on the region 2B cyst membrane is decreased by *bsk* RNAi. Germaria are outlined with dotted lines. Scale bars, 10 μm. (**G**) Quantification of background subtracted InR-EGFP intensity on cell membrane of the region 2B cyst. n = 7 germaria for each genotype. Error bars represent SEM. \*p\<0.005. (**H**) Germaria from ovaries of *bsk^RNAi^; bsk^RNAi^*, *InR^OE^; jra^RNAi^; jra^RNAi^*, *InR^OE^* driven by *nos*-Gal4 endogenously expressing Myc-GFP co-stained with anti-GFP and anti-1B1. Note that Myc-GFP level in germ cells is markedly lower than that in follicle cells pointed out by arrows. Scale bars, 10 μm. (**I**) COX activity in region 2B cysts from ovaries with indicated genotypes. The activities are normalized to that of region 2B cysts from the *ctrl* line. n = 10 germaria for each genotype. Error bars represent SEM. \*p\<0.005.\
10.7554/eLife.49309.018Figure 5---source data 1.Relative mtDNA area, p-AKT intensity, InR-EGFP intensity, and COX activity in the germarium.](elife-49309-fig5){#fig5}

IIS was elevated in region 2B and remained active until stage-10 egg chambers, the same period during which ETC biogenesis and mtDNA replication are active. However, JNK is only transiently activated in the region 2B cysts. Therefore, additional regulations must be involved to maintain IIS activity after JNK activity subsides. Our RNAseq results showed that *InR* mRNA was downregulated in the *myc^P0^* ovary compared with controls ([Supplementary file 2](#supp2){ref-type="supplementary-material"}), suggesting that Myc might activate *InR* transcription. Indeed, both *InR* mRNA level measured by FISH and IIS activity indicated by p-AKT were reduced in *myc^P0^* mutant or *chico* RNAi ovaries ([Figure 6A--D](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). Importantly, over-expression of *myc* using *bam*-Gal4 in region 2A ectopically induced *InR* transcription and IIS activity ([Figure 6A--D](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}), suggesting that Myc can indeed increase IIS activity by boosting *InR* expression. Together, our results highlight an IIS-Myc-positive feedback loop that promotes respiration and mtDNA replication in the ovary.

![A positive feedback regulatory loop between IIS and Myc.\
(**A**) Visualization of the *InR* mRNA by FISH with fluorescently labeled DNA probes in germaria from *ctrl*, *chico^RNAi^*, *myc^P0^*, and *bam* \>*myc^OE^* ovaries. Germaria are outlined with dotted lines. Reduction in either IIS or Myc depletes *InR* mRNA in the germarium, while *myc* over-expression in region 2A ectopically induces *InR* mRNA. Scale bars, 5 μm. (**B**) Quantification of *InR* mRNA intensity from cysts in germarium region 2A and 2B of ovaries with indicated genotypes. Intensities are normalized to the value of *ctrl* at region 2B. n = 8, 8, 8, and 9 germaria for *ctrl*, *chico^RNAi^*, *myc^P0^*, and *bam* \>*myc^OE^*, respectively. Error bars represent SEM. \*p\<0.05. (**C**) Germaria from *ctrl*, *chico^RNAi^*, *myc^P0^*, and *bam* \>*myc^OE^* ovaries stained with anti-p-AKT and anti-1B1. Decrease in either IIS or Myc reduces IIS activity in the germarium, while *myc* over-expression in region 2A ectopically induces IIS activity. Scale bars, 5 μm. (**D**) Quantification of p-AKT intensity in region 2A and 2B cysts of ovaries with indicated genotypes. Intensities are normalized to the value of *ctrl* at region 2B. n = 11 germaria for each genotype. Error bars represent SEM. \*p\<0.005.\
10.7554/eLife.49309.022Figure 6---source data 1.Relative *InR* mRNA density and p-AKT intensity in the germarium.](elife-49309-fig6){#fig6}

The JNK-IIS-Myc relay is essential for female fertility and mtDNA selective inheritance {#s2-7}
---------------------------------------------------------------------------------------

So far, we have established that the JNK-IIS-Myc relay is critical for ETC activity, mtDNA expression, replication, and transmission in the ovary. Next, we explored its physiological impact on reproduction. While both *chico* mutant females and those with germline clones of *bsk^1^* produced similar amount of eggs as controls, they failed to generate adequate amount of mtDNA to deposit in eggs ([Figure 7A](#fig7){ref-type="fig"}). Thus, their eggs had significantly reduced mtDNA level and hatching rates ([Figure 7B](#fig7){ref-type="fig"}).

![JNK-IIS relay is essential for mtDNA selective inheritance and fertility.\
(**A**) Quantification of relative mtDNA content in eggs produced by mothers carrying germline clones (GLCs) of *bsk^1^* or by *chico^1^*^/*KG*^ mutant mother. Relative mtDNA levels are determined by qPCR for *mt:CoI* and *his4* copies, and normalized to the level in wt. n = 12, 16, and 12 mothers for wt, *bsk^1^*, and *chico^1^*^/*KG*^. Error bars represent SEM. \*p\<0.005. (**B**) The hatching rate of eggs produced by female flies carrying *bsk^1^* GLCs or *chico^1^*^/*KG*^ females is significantly lower than that of wt eggs. n = 5 × 40 eggs for each genotype. Error bars represent SEM. \*p\<0.005. (**C**) Quantification of *mt:Col^T300I^* transmission from females with indicated nuclear genotypes. In wt females, the mtDNA mutation is counter-selected, resulting in \~20% fewer mutant mtDNA in the progeny than in the mothers. This counter-selection is diminished in *chico^1^*^/*KG*^ mutant mothers of in mothers expressing *bsk^RNAi^* driven by *nos*-Gal4. Mothers heteroplasmic for *mt:Col^T300I^* were cultured at 29°C. n = 10 mothers for each genotype. Error bars represent SEM. \*p\<0.005. (**D**) Schematics of the developmental signaling relay initiated from late germarium that primes mitochondrial respiration, and mtDNA replication and inheritance.\
10.7554/eLife.49309.024Figure 7---source data 1.Relative mtDNA level in eggs, % hatched eggs, and % change of *ts* in eggs.](elife-49309-fig7){#fig7}

During oogenesis, prodigious mtDNA replication not only furnishes mature oocytes with adequate amounts of mtDNA to support the early embryogenesis, it also affords the replication competition that allows the wild-type mitochondrial genomes to out-compete mtDNA carrying deleterious mutations ([@bib24]). Thus, we asked whether inhibition of IIS and JNK signaling, which impairs mtDNA replication, would also diminish selective inheritance in heteroplasmic females harboring both wt and a temperature-sensitive lethal mutation, *mt:CoI^T300I^* ([@bib24]). Consistent with previous studies, eggs contained \~20% less *mt:CoI^T300I^* mtDNA on average than their mothers at restrictive temperature in controls ([Figure 7C](#fig7){ref-type="fig"}). However, this counter-selection of the *mt:CoI^T300I^* genome was greatly diminished by downregulation of either IIS or JNK signaling ([Figure 7C](#fig7){ref-type="fig"}). Together, these results stress that although JNK is transiently activated in the late germarium, it triggers a developmental signaling relay that has profound impacts on mitochondrial inheritance through activation of mitochondrial biogenesis, including ETC biogenesis and mtDNA replication.

Discussion {#s3}
==========

mtDNA replication in the *Drosophila* ovary relies on active respiration ([@bib24]), suggesting that ETC activity and mtDNA replication might be subject to the same spatio-temporal regulation. In this study, we address this question and further elucidate the developmental mechanisms regulating ETC activity and mtDNA biogenesis in the ovary. Utilizing the COX/SDH dual activity staining, we reveal that ETC complexes are inactive in the germline stem cells (GSCs) and dividing cysts from germarium region 1 to 2A, but sharply activated in region 2B and active through stage-10 follicles. This spatial pattern mirrors that of mtDNA replication in the *Drosophila* ovary, supporting an essential role of mitochondrial respiration in mtDNA inheritance, both quantitively and qualitatively. We also demonstrate that ETC activation is accompanied with an upregulation of the expression of ETC genes of both nuclear and mitochondrial origin. Interestingly, MDI, which drives the local translation of nuclear encoded mitochondrial proteins on the mitochondrial outer membrane and TFAM, which governs mtDNA replication and transcription ([@bib16]; [@bib72]), exhibit the same developmental pattern as mitochondrial respiration in the germarium. Collectively, these proteins would boost the biogenesis of ETC in region 2B of the germarium and in growing egg chambers. In an ovariole, different stages of developing germ cells reside in the same microenvironment and experience the same oxygen tension. Thus, the mitochondrial respiratory activity is likely to be determined by the abundance of ETC components, which itself is controlled by transcriptional activation.

To understand how mitochondrial respiration is regulated, we conducted an RNAi screen for genes that boost COX/SDH activity in the ovary. The *myc* gene emerged as one of the strongest hits, and a hypomorphic allele, *myc^P0^*, largely abolished ETC activity and mtDNA replication in the germarium. Moreover, the spatial pattern of Myc protein mirrors mtDNA replication and ETC activity, further supporting its essential role in transcriptional activation of ETC biogenesis. RNA sequencing data demonstrate that Myc broadly stimulates gene expression in the *Drosophila* ovary, including many nuclear-encoded ETC genes and factors required for mtDNA replication and expression. Our observations are consistent with previous studies in mammals showing that MYC can promote mitochondrial biogenesis by directly elevating the expression of nuclear-encoded mitochondrial genes ([@bib31]; [@bib33]; [@bib63]). Among 198 annotated human mitochondrial genes that are up-regulated by Myc overexpression ([@bib33]), 185 have homologs in the *Drosophila* genome ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). Of note, 44.9% (101 out of 225) of the fly homologs are down-regulated in *myc^P0^* mutant ovaries ([Supplementary file 6](#supp6){ref-type="supplementary-material"}), suggesting an evolutionarily conserved function of Myc in regulating mitochondrial biogenesis through gene expression. Our finding that Myc induces ETC biogenesis and respiration is also in line with the studies in mammals demonstrating the multi-faceted roles of Myc in the regulation of mitochondria, including boosting mitochondrial biogenesis ([@bib1]; [@bib31]; [@bib63]), stimulating oxidative metabolism ([@bib1]), and regulating mitochondrial structure and dynamics ([@bib21]).

Myc overexpression sometimes gives rise to different transcriptional output in different cell types ([@bib13]). This observation reflects the fact that Myc-family proteins often associate with other cofactors and exert a broad and complex transcriptional role in a cell- or tissue-specific manner ([@bib11]; [@bib23]). We also found that 130 transcription regulators, including *Srl* (fly homolog of human PGC-1) and CG32343 (fly homolog of GABPB2), were affected by the *myc^P0^* mutation. PGC-1 proteins belong to an evolutionarily conserved family that integrates mitochondrial biogenesis and energy metabolism with a variety of cellular processes ([@bib34]). In *Drosophila*, *Srl* regulates the expression of a subset of nuclear encoded mitochondrial genes ([@bib66]). Mammalian GABPB2 is a regulatory subunit of the Nuclear Respiratory Factor complex 2 that regulates the expression of a small set of nuclear encoded mitochondrial proteins ([@bib30]). Therefore, additional tiers of transcriptional regulations downstream of Myc are likely involved in boosting ETC biogenesis.

While *myc* transcription is uniform in the germarium, Myc protein is elevated at region 2B and remains high until the stage-10 egg chamber, indicating that Myc abundance is mainly regulated *via* post transcriptional mechanisms. IIS and JNK also emerged from our RNAi screen, and both were further confirmed to be required for triggering ETC biogenesis and mtDNA replication. We found that IIS activity, marked by both p-AKT and p-GSK3 staining, displayed a pattern similar to that of Myc. Additionally, elevated IIS activity was required to establish a high level of Myc and to activate ETC in the late germarium stage. GSK3 directly phosphorylates Myc and promotes its ubiquitination and degradation in both mammalian and fly cultured cells ([@bib18]; [@bib26]; [@bib57]). Thus, IIS likely stabilizes Myc protein by inhibiting GSK activity. Our result is also in line with a previous study showing that decreased IIS activity relieves the inhibition on GSK3, which leads to mitochondrial quiescence at later stages of oogenesis ([@bib58]). Importantly, our work uncovers Myc as the downstream effector of IIS in the regulation of respiration and mtDNA biogenesis in the ovary.

We noticed that *InR* transcription was down-regulated in the *myc* mutant ovary, suggesting a positive feedback regulation between IIS and Myc. This regulatory loop maintains high levels of both Myc protein and IIS activity in the mid-stage follicles, where massive mitochondrial biogenesis and massive cell growth take place. However, it does not explain how this loop is activated in the first place at the late germarium stages. We found that JNK was transiently activated in germ cells in the germarium region 2B, but decreased in budding egg chambers and sharply diminished thereafter. High level and sustained JNK activity often lead to apoptosis. However, cell death is rarely observed in the germaria of flies cultured under normal conditions. Thus, JNK activation in the late germarium must be triggered by cellular processes unrelated to apoptosis. We reveal that transiently elevated JNK activity is sufficient to increase *InR* mRNA level, which in-turn boosts IIS activity and stabilizes Myc protein. Currently, the link between JNK and IIS is not well-understood. In the metastatic *Drosophila* epithelium, cell survival and proliferation entail upregulation of *InR* expression by JNK through wingless signaling ([@bib25]). However, no genes in the wingless signaling pathway emerged from our RNAi screen in germ cells. The molecular mechanisms that links JNK activation to *InR* expression in ovary remain to be explored.

The JNK-dependent transcriptional program can be activated by various cellular stresses and cell-cell signaling events ([@bib54]). In region 2B of the germarium, the follicle cells extend and migrate laterally across the germarium to wrap around the 16 cells cyst ([@bib41]). Thus, JNK activation in germ cells may reflect paracrine signaling from the follicle cells, for instance via TNF-α. Alternatively, the process of follicle cells enveloping and compressing the 16-cell cyst may generate mechanical stress that subsequently activates JNK. Regardless, our work uncovers a novel function of JNK in energy metabolism and mitochondrial biogenesis besides its well-established roles in controlling cell apoptosis, growth, and proliferation.

Studies in a variety of animal models have shown that reproductive aging in females is tightly associated with decreased IIS activity ([@bib65]). Interestingly, oocytes of aged females often have higher incidence of mtDNA lesions and lower mtDNA copy number ([@bib7]). Thus, developmental control of mitochondrial biogenesis and mtDNA replication via IIS may be a conserved mechanism in metazoans. Our previous studies demonstrated that prodigious mitochondrial biogenesis during oogenesis underlies the selective inheritance of functional mtDNA by allowing proliferation competition between healthy mitochondria and mitochondria carrying deleterious mtDNA mutations ([@bib73]). Here, we uncover that the JNK/IIS/Myc signaling relay governs mitochondrial biogenesis in the ovary, and thereby influences mitochondrial inheritance both quantitively and quantitively. Our studies could provide a molecular framework to further understand the control of mitochondrial biogenesis and mtDNA inheritance in animals.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource    Designation                                     Source or reference                    Identifiers                                                                                                               Additional information
  ------------------------------------- ----------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------
  Genetic reagent (*D. melanogaster*)   *w^1118^* (wt)                                  [@bib73]                               <https://doi.org/10.1016/j.molcel.2019.01.013>                                                                            

  Genetic reagent (*D. melanogaster*)   *ts* (*mt:Col^T300I^%*)                         [@bib24]                               <https://doi.org/10.1038/ng.2920>                                                                                         

  Genetic reagent (*D. melanogaster*)   *UAS-Dcr-2*; *nos*-Gal4                         Bloomington Drosophila Stock Center    BDSC: 25751 FLYB: FBti0101430 FLYB: FBti0012287                                                                           FLYB symbol: P{UAS-Dcr-2.D}1 P{GAL4-nos.NGT}40

  Genetic reagent (*D. melanogaster*)   *nos*-Gal4                                      Bloomington Drosophila Stock Center    BDSC: 32563 FLYB: FBti0012287                                                                                             FLYB symbol: P{GAL4-nos.NGT}40

  Genetic reagent (*D. melanogaster*)   *bam*-Gal4                                      [@bib8]                                <https://doi.org/10.1242/dev.00325>                                                                                       

  Genetic reagent (*D. melanogaster*)   *UAS-LacZ*                                      [@bib69]                               <https://doi.org/10.1093/hmg/ddw067>                                                                                      *ctrl* over-expression

  Genetic reagent (*D. melanogaster*)   *myc^P0^*                                       [@bib27]                               [https://doi.org/10.1016/S0092-8674(00)81512--3](https://doi.org/<br%20/>10.1016/S0092-<br%20/>8674(00)81512%E2%80%933)   

  Genetic reagent (*D. melanogaster*)   *myc-LacZ*                                      Bloomington Drosophila Stock Center    BDSC: 12247 FLYB: FBti0015660                                                                                             FLYB symbol: P{lacW}Myc^G0359^

  Genetic reagent (*D. melanogaster*)   *puc-LacZ*                                      Bloomington Drosophila Stock Center    BDSC: 11173 FLYB: FBti0005134                                                                                             FLYB symbol: P{lArB}puc^A251.1F3^

  Genetic reagent (*D. melanogaster*)   *UAS-myc*                                       ([@bib53])                             <https://doi.org/10.1242/dev.033340>                                                                                      

  Genetic reagent (*D. melanogaster*)   *bsk^1^*, FRT40A                                ([@bib6])                              <https://doi.org/10.1016/j.neuron.2015.10.023>                                                                            

  Genetic reagent (*D. melanogaster*)   hs-FLP; ubi-mRFP, FRT40A                        ([@bib6])                              <https://doi.org/10.1016/j.neuron.2015.10.023>                                                                            

  Genetic reagent (*D. melanogaster*)   *luciferase^RNAi^*                              Bloomington Drosophila Stock Center    BDSC: 31603\                                                                                                              FLYB symbol: P{TRiP.JF01355}attP2 ctrl RNAi
                                                                                                                               FLYB: FBti0130444                                                                                                         

  Genetic reagent (*D. melanogaster*)   *sgg^RNAi^*                                     Bloomington Drosophila Stock Center    BDSC: 35364 FLYB: FBst0035364                                                                                             FLYB symbol:\
                                                                                                                                                                                                                                                         P{TRiP.GL00277}attP2

  Genetic reagent (*D. melanogaster*)   *thor^RNAi^*                                    Bloomington Drosophila Stock Center    BDSC: 36815 FLYB: FBst0036815                                                                                             FLYB symbol: P{TRiP.GL01034}attP2

  Genetic reagent (*D. melanogaster*)   *puc^RNAi^*                                     Bloomington Drosophila Stock Center    BDSC: 36085 FLYB: FBst0036085                                                                                             FLYB symbol: P{TRiP.GL00504}attP40

  Genetic reagent (*D. melanogaster*)   *UAS-InR*                                       Bloomington Drosophila Stock Center    BDSC: 8262\                                                                                                               FLYB symbol: P{UAS-InR.Exel}2
                                                                                                                               FLYB: FBst0008262                                                                                                         

  Genetic reagent (*D. melanogaster*)   *chico^1^*                                      Bloomington Drosophila Stock Center    BDSC: 10738 FLYB: FBst0010738                                                                                             FLYB symbol: P{ry11}chico^1^/CyO

  Genetic reagent (*D. melanogaster*)   *chico^KG^*                                     Bloomington Drosophila Stock Center    BDSC: 14337 FLYB: FBst0014337                                                                                             FLYB symbol:\
                                                                                                                                                                                                                                                         P{SUPor-P}chico^KG00032^

  Genetic reagent (*D. melanogaster*)   Myc-GFP                                         Bloomington Drosophila Stock Center    BDSC: 81274 FLYB: FBti0147732                                                                                             FLYB symbol: PBac{y^+^-attP-3B}VK00033

  Genetic reagent (*D. melanogaster*)   Sgg-GFP                                         Bloomington Drosophila Stock Center    BDSC: 66770 FLYB: FBst0066770                                                                                             FLYB symbol: Mi{PT-GFSTF.1}sgg^MI11971-GFSTF.1^

  Genetic reagent (*D. melanogaster*)   PDK1-GFP                                        Bloomington Drosophila Stock Center    BDSC: 59836 FLYB: FBst0059836                                                                                             FLYB symbol: Mi{PT-GFSTF.0}Pdk1^MI06823-GFSTF.0^

  Genetic reagent (*D. melanogaster*)   myc-Dp110                                       Bloomington Drosophila Stock Center    BDSC: 25915 FLYB: FBst0025915                                                                                             FLYB symbol: P{Myc-Dp110}1

  Genetic reagent (*D. melanogaster*)   Chico-GFP                                       Vienna Drosophila RNAi Center          VDRC: v318104\                                                                                                            FLYB symbol: PBac{fTRG00456.sfGFP-TVPTBF}VK00033
                                                                                                                               FLYB: FBst0491524                                                                                                         

  Genetic reagent (*D. melanogaster*)   InR-EGFP                                        This paper                             HX lab                                                                                                                    EGFP inserted before the stop codon of InR genomic locus

  Genetic reagent (*D. melanogaster*)   UAS-FLP                                         Bloomington Drosophila Stock Center    BDSC: 29731 FLYB: FBti0128596                                                                                             FLYB symbol: P{w\[+mC\]=UASp FLP.G}3

  Genetic reagent (*D. melanogaster*)   TM3, Sb^1^, Ser^1^/TM6B, Tb^1^                  Bloomington Drosophila Stock Center    BDSC: 2537 FLYB: FBst0002537                                                                                              FLYB symbol: TM3, Sb\[1\] Ser\[1\]/TM6B, Tb\[1\]

  Antibody                              Mouse monoclonal anti-GFP                       Roche                                  11814460001                                                                                                               IF(1:1000)

  Antibody                              Mouse monoclonal anti-Hts                       Developmental Studies Hybridoma Bank   1B1                                                                                                                       IF(1:1000)

  Antibody                              Mouse monoclonal anti-ATP5A                     ATP5A                                  ab14748                                                                                                                   IF(1:400)

  Antibody                              Rabbit polyclonal anti-GFP                      Novus                                  NB600-308                                                                                                                 IF(1:1000)

  Antibody                              Rabbit polyclonal anti-dMyc                     Santa Cruz Biotechnology               d1-717                                                                                                                    IF(1:200)

  Antibody                              Rabbit polyclonal anti-Vasa                     Santa Cruz Biotechnology               sc-30210                                                                                                                  IF(1:500)

  Antibody                              Rabbit monoclonal anti-p-GSK3                   Cell Signaling Technology              9323S                                                                                                                     IF(1:200)

  Antibody                              Mouse monoclonal anti-GSK3                      Cell Signaling Technology              9832S                                                                                                                     IF(1:200)

  Antibody                              Rabbit polyclonal anti-AKT                      Cell Signaling Technology              9272S                                                                                                                     IF(1:200)

  Antibody                              Rabbit polyclonal anti-p-AKT                    Cell Signaling Technology              4054S                                                                                                                     IF(1:200)

  Antibody                              Mouse monoclonal β-galactosidase                Promega                                Z378A                                                                                                                     IF(1:1000)

  Peptide, recombinant protein          Cytochrome c from equine heart                  Sigma-Aldrich                          C7752                                                                                                                     COX histochemistry staining

  Peptide, recombinant protein          Catalase from bovine liver                      Sigma-Aldrich                          C9322                                                                                                                     COX histochemistry staining

  Chemical compound, drug               TMRM                                            Thermo Fisher Scientific               I34361                                                                                                                    1:10000 on dissected ovaries

  Chemical compound, drug               MitoTracker Green                               Thermo Fisher Scientific               M7514                                                                                                                     1:10000 on dissected ovaries

  Chemical compound, drug               3,3′-Diaminobenzidine tetrahydrochloride        Sigma-Aldrich                          D5905                                                                                                                     COX histochemistry staining

  Chemical compound, drug               Nitrotetrazolium Blue chloride                  Sigma-Aldrich                          N6876                                                                                                                     COX/SDH dual histochemistry staining

  Chemical compound, drug               Phenazine methosulfate                          Sigma-Aldrich                          P9625                                                                                                                     COX/SDH dual histochemistry staining

  Chemical compound, drug               Sodium succinate                                Sigma-Aldrich                          S2378                                                                                                                     COX/SDH dual histochemistry staining

  Chemical compound, drug               Heparin ammonium salt                           Sigma-Aldrich                          H6279                                                                                                                     RNA FISH

  Other                                 Salmon Sperm DNA                                Invitrogen                             15632011                                                                                                                  RNA FISH

  Commercial assay, kit                 Click-iT Plus EdU Alexa Fluor 488 Imaging Kit   Thermo Fisher Scientific               C10637                                                                                                                    labeling replicating mtDNA

  Commercial assay, kit                 Ribo-Zero rRNA Removal Kit                      Illumina Inc.                          MRZH116                                                                                                                   Used in RNA preparation for RNAseq

  Sequence-based reagent                *InR* chiRNA targeting sequence                 This paper                             HX lab                                                                                                                    CCTTTCCGTAGATGGATGACACC

  Sequence-based reagent                InR-F1                                          This paper                             HX lab                                                                                                                    ATGATGTCATCGGTGGGTCCTCAC

  Sequence-based reagent                EGFP-seqR                                       This paper                             HX lab                                                                                                                    CTTGTAGTTGCCGTCGTCCTTGAA

  Sequence-based reagent                InR-F2                                          This paper                             HX lab                                                                                                                    AGCACATTGTGTCAGTCTTCG

  Sequence-based reagent                InR-R                                           This paper                             HX lab                                                                                                                    CTCATTTTCCGAAGCTTGGCTTCC

  Sequence-based reagent                *mt:CoI*, Xho1 site genotyping F                [@bib24]                               <https://doi.org/10.1038/ng.2920>                                                                                         TGGAGCTATTGGAGGACTAAATCA

  Sequence-based reagent                *mt:CoI*, Xho1 site genotyping R                [@bib24]                               <https://doi.org/10.1038/ng.2920>                                                                                         GCTCCTGTTAATGGTCATGGACT

  Sequence-based reagent                qPCR, *his4*-F                                  [@bib71]                               <https://doi.org/10.15252/embr.201439636>                                                                                 TCCAAGGTATCACGAAGCC

  Sequence-based reagent                qPCR, *his4*-R                                  ([@bib71])                             <https://doi.org/10.15252/embr.201439636>                                                                                 AACCTTCAGAACGCCAC

  Sequence-based reagent                qPCR, *mt:CoI*-F                                ([@bib71])                             <https://doi.org/10.15252/embr.201439636>                                                                                 ATTGGAGTTAATTTAACATTTTTTCCTCA

  Sequence-based reagent                qPCR, *mt:CoI-R*                                [@bib71]                               <https://doi.org/10.15252/embr.201439636>                                                                                 AGTTGATACAATATTTCATGTTGTGTAAG

  Software, algorithm                   ImageJ                                          NIH                                    <https://imagej.nih.gov/ij/>                                                                                              

  Scoftware, algorithm                  GraphPad Prism7                                 GraphPad Software, Inc                 <http://www.graphpad.com/>                                                                                                
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly stocks and genetics {#s4-1}
-----------------------

Flies were maintained on standard BDSC cornmeal medium at 25°C. RNAi lines for candidate screen are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Embryo hatch assay was performed as previously described ([@bib73]). To control the genetic background, *chico^KG^*, *chico^1^*, *ts* and *myc^P0^* strains were back-crossed with *w^1118^* for six generations.

CRISPR/Cas9 in flies {#s4-2}
--------------------

To tag *InR* with EGFP at its endogenous locus, a targeting cassette comprising of 1 kb upstream of I*nR* stop codon, *EGFP* ORF, a fragment containing *GMR-Hid* flanked by two FRT sites, and 1 kb downstream of *InR* stop codon was inserted into a pOT2 vector. This donor construct and a *InR* chiRNA construct were injected into the embryos of *M{vas-Cas9}ZH-2A* (BL51323) by Bestgene Inc.. G0 adults were crossed with w1118, and progeny with small eye phenotype were selected as candidates due to the expression of *GMR-Hid*. Insertion events were further confirmed by PCR using two pairs of primers: 1, InR-F1/EGFP-seqR and 2, InR-F2/InR-R. To remove the *GMR-Hid* cassette, the *InR-EGFP-GMR-Hid* flies were crossed with *nos-Gal4; UASp-FLP*. The F1 progeny with the genotype of *nos-Gal4/+; UASp-FLP/InR-EGFP-GMR-Hid* were selected and crossed with *TM3, Sb1, Ser1/TM6B, Tb1*. The F2 flies of *InR-EGFP/TM6B, Tb1* with normal white eyes were selected and maintained.

Measurement of mtDNA copy number and quantification of heteroplasmy {#s4-3}
-------------------------------------------------------------------

Total DNA was isolated from eggs with QIAamp DNA Micro Kit (Qiagen). The mtDNA copy number was measured by quantitative real-time PCR with primers targeting to cytochrome c oxidase subunit I (mt:CoI) and His4 genes. Quantification of heteroplasmy was performed as described previously by qPCR ([@bib73]), with primer pairs: his4-F/his4-R: and mt:CoI-F/mt:CoI-R. Heteroplasmic female flies were transferred from 18°C to 29°C after eclosion. Each female was mated with five wt males. Ten eggs produced from the day 7 at 29°C were collected. The genomic DNA from female flies and eggs was extracted and their heteroplasmy levels were determined as shown before ([@bib24]), with primers: *mt:CoI*, Xho1 site genotyping F and *mt:CoI*, Xho1 site genotyping R.

RNA sequencing and RNA-seq analysis {#s4-4}
-----------------------------------

Total RNA was extracted by Trizol (Life Technologies) following its standard protocol. Poly (A) capture libraries were generated at the DNA Sequencing and Genomics Core, NHLBI, NIH. RNA sequencing was performed with using an Hiseq3000 (Illumina) and 75 bp pair-end reads were generated at the DNA Sequencing and Genomics Core, NHLBI, NIH. Raw sequence reads were quality-trimmed using Trim Galore! (v0.3.7) and aligned using HISAT2 against the Dm6 reference genome. Uniquely mapped paired-end reads were then used for subsequent analyses. FeatureCounts was used for gene level abundance estimation. Principal component analysis (PCA) was used to assess outlier samples. Genes were kept in the analysis if they had Counts Per Million (CPM \> 1) in at least half the samples. We adjusted for multiple testing by reporting the FDR q-values for each feature. Features with q \< 5% were declared as genome-wide significant. Genes with three or more-fold changes on mRNA level in *myc^P0^* mutant compared with wt were considered differentially expressed. Gene Ontology (GO) was used to analyze gene set enrichment. FDR q-values were estimated to correct the p-values for the multiple testing issue.

To evaluate the enrichment of genes associated with mitochondrial processes in our decreased genes, we performed an approximate permutation test or resampling approach ([@bib9]; [@bib20]; [@bib49]), with null hypothesis that there is no difference between expression of mitochondrial and non-mitochondrial genes. The approach was performed by randomly selecting an equal number of genes (4,733) from the entire observed genome that were expressed in our study and were matched by gene size (±10 kb) as well as the GC content (±20%) with our observed genes. We repeated this process 10,000 times to calculate the empirical p-value, the number of times that the number of mitochondrial genes in the randomly drawn genes was greater than what was found in the observed set (458). The permutation empirical p-value was p\<10^−4^ indicating that there is a significant enrichment for genes associated with mitochondrial processes in our decreased gene list.

Myc target analysis dMyc enriched binding regions that is peak files were downloaded from the Gene Expression Omnibus (GEO) repository ([@bib3]; [@bib15]). The accession numbers of the downloaded files are GSE53560, GSE53559, and GSE49774 ([@bib59]). Using an in-house R script and Bedtools utility ([@bib51]), the peaks were annotated to *Drosophila melanogaster*\'s genome using Ensembl V(91) annotation ([@bib2]) to identify downstream targets of dMyc. If a ChIP-seq peak from any one of the datasets was observed between 250 base-pairs upstream to 100 base-pair downstream of a gene\'s transcription start site, then the gene was assumed to be putative downstream targets of dMyc. To reduce the false positives that could potentially arise due to different origins of tissues in RNA-seq and ChIP-seq data, only those genes that were both differentially expressed and had a ChIP-seq peak were considered as putative targets of dMYC.

Live image {#s4-5}
----------

Live image of fly ovaries was performed as previously reported ([@bib73]). Ovaries from wt flies were stained with TMRM (1:10000, I34361, Thermo Fisher Scientific) and MTgreen (1:10000, M7514, Thermo Fisher Scientific) in PBS for 20 min followed by PBS washes for three times. Ovaries from Sgg-GFP flies were dissected. Ovarioles were isolated and immerged in halocarbon oil on coverslips, then live imaged with a Perkin Elmer Ultraview system. The ratiometric image was generated with ImageJ, which the intensity of red channel is divided by that of green channel.

SDH and COX activity staining in the ovary {#s4-6}
------------------------------------------

To determine if changes in the intensities of COX staining linearly or exponentially correlate with the activities/amounts of complexes IV in the ovary, we generated standards for COX staining by blotting various amount of Cytochrome c oxidase (C5499, Sigma, for the COX standards) on a nitrocellulose membrane with a slot blotting apparatus (Bio-Dot SF Apparatus). COX staining solution contains 50 mM phosphate (pH 7.4), 4 mM 3,3'-diaminobenzidine, 2 μg/ml catalase, 200 μM cytochrome c, 84 mM malonate, 60 μM rotenone and 4 mM antimycin A. The nitrocellulose membrane blotted with COX was incubated in the COX staining solution at room temperature for 30 min. The reaction was stopped by incubation with 4% paraformaldehyde for 15 mins. Membrane was then washed twice in 50 mM phosphate (pH 7.4) and scanned. The intensities of bands were quantified using the 'Gels' function in ImageJ. Band intensities and the according amounts of mitochondria or Cytochrome c oxidase were plotted in Excel. Trendlines were generated based on linear or exponential relation, respectively. We found that R^2^ values of linear correlation are 0.9919 for COX activity standards, while R^2^ values of exponential correlation are reduced to 0.8658.

For COX/SDH dual activity staining, five pairs of ovaries were dissected in PBS and intact ovarioles were separated with a dissection needle. Ovaries were incubated alive with COX staining solution for 30 min, followed by three washes in 50 mM phosphate (pH 7.4) for 5 min each. Ovaries were then incubated for 10 min in the SDH staining solution, containing 50 mM phosphate (pH 7.4), 42 mM succinic acid, 0.4 mM phenazine methosulfate, 0.5 mM nitro blue tetrazolium, 4.5 mM EDTA, 60 μM rotenone, 4 mM antimycin A and 2 mM KCN. Ovaries were then washed twice in 50 mM phosphate (pH 7.4) for 5 min each and 4% paraformaldehyde fixation for 15 mins. Then, ovaries were washed for twice in 50 mM phosphate (pH 7.4) for 5 min each and immersed in 80% glycerol in 50 mM phosphate (pH 7.4). For COX single activity staining, 8 to 10 pairs of ovaries were dissected in PBS and intact ovarioles were separated with a dissection needle. Ovaries from the same genotype were divided into two groups and incubated alive with COX staining solution for 30 min. No saturation was observed for either staining. For the negative control, ovaries (*w^1118^* or *luciferase^RNAi^*) were incubated with COX staining solution added with a complex IV inhibitor (2 mM KCN). The negative controls of COX staining were performed for each batch of ETC activity staining. The reactions were followed by two washes in 50 mM phosphate (pH 7.4) for 5 min each and 4% paraformaldehyde fixation for 15 min. Then, ovaries were washed for twice in 50 mM phosphate (pH 7.4) for 5 min each and immersed in 80% glycerol in 50 mM phosphate (pH 7.4). Brightfield germarium images were collected by Zeiss Axio Observer Z1 microscope.

Quantification for relative ETC activities in the germarium was performed using ImageJ. From the opened images, germline cysts were isolated by 'Clear Outside'. Color of the cysts was inverted and converted into gray. 'Color Threshold' was used to select COX staining. Intensity of selected staining area was measured. Intensity of non-selected area was considered as background and subtracted from the intensity of selected area. From each batch of activity staining, the COX activity was calculated by normalizing the staining intensities in the germarium to the COX activity standard curves. The intensity from the negative control group, with addition of inhibitor for COX, was considered as '0' activity, while the intensity from the control groups was considered as a relative '1' activity.

Immunofluorescence staining and fluorescence in situ hybridization (FISH) {#s4-7}
-------------------------------------------------------------------------

Ovary dissection, immunostaining, and EdU incorporation were performed as described before ([@bib24]). Click-iT Plus EdU Alexa Fluor 488 Imaging Kit (C10637, Thermo Fisher Scientific) was used for EdU incorporation and visualization. Stellaris FISH probes against, *Cyt-C1*, *Cyt-B*, *CoxIV*, *CoxIII*, or *InR* mRNA were synthesized from Biosearch Technologies. Sequences of the probes are listed in the [Supplementary file 7](#supp7){ref-type="supplementary-material"}. FISH of *Drosophila* ovaries was conducted as previously described ([@bib67]). Confocal images were collected by a Perkin Elmer Ultraview system or Instant Sim (iSIM) Super-Resolution Microscope. All images were processed with Image J.

Quantification and statistical analysis {#s4-8}
---------------------------------------

All statistical analyses were conducted with Prism 7 (GraphPad Software). Error bars in all charts represent standard errors. p-Values were performed with Two‐tailed Student's t test. Statistical significance of difference was considered when p\<0.05.

Data availability {#s4-9}
-----------------

The data were deposited in Gene Expression Omnibus of NCBI ([@bib15]) and will be available with accession number (GEO: GSE126997).
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Decision letter

Bellen

Hugo J

Reviewing Editor

Baylor College of Medicine

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Electron transport chain biogenesis activated by a JNK-insulin-Myc relay primes mitochondrial inheritance in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Hugo Bellen as the Reviewing Editor and Michael Eisen as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Wang et al. further describe the role of insulin/GSK3 signaling in the regulation of mitochondria during germ cell development. While insulin/GSK3 signaling has been previously shown to have a major effect on germ line mitochondrial activity, this study highlights the extensive interplay between the pathway and mitochondrial function by showing the pathway is required for mtDNA replication. The authors extend these findings to show that insulin-Myc and JNK signaling coordinate germ cell mitochondrial biogenesis with developmental progression. Overall this study addresses a fundamental question in germ cell biology and provides valuable insight into how developmental signaling pathways coordinate mitochondrial biogenesis with developmental progression. However, the authors overstate their results regarding the specific effects on ETC regulation and mitochondrial inheritance. The authors also lack a few controls and rescue experiments that support their key findings. Once these issues are corrected this study will provide a valuable contribution to our understanding of how mitochondrial biogenesis is coupled to early germ cell development.

Positive aspects of the paper:

• The authors show clear and significant roles of insulin, GSK3, Myc, and JNK signaling on mitochondrial replication in early developing germ cells.

• The phenotypes described are highly consistent with previous studies that describe the molecular mechanisms that underlie the insulin/GSK3/Myc pathway.

• The authors also nicely show that the changes in mtDNA they describe correspond with reduced levels of SDH and COX activity.

• The authors show, consistent with previous studies from Chi V. Dang\'s lab, that Myc plays an in vivo role in the regulation of mitochondrial gene expression and mitochondrial biogenesis.

Overall weaknesses:

• The authors imply that JNK-insulin-Myc signaling has specific roles in ETC activity, mtDNA replication, and mitochondrial inheritance. However, the most consistent model is that the effects on ETC activity and mitochondrial inheritance the authors observed simply stem from changes in mitochondrial number.

• The authors don\'t provide adequate genetic background controls for many of their key experiments.

• The authors fail to adequately present what is known from previous literature regarding Myc regulation of mitochondrial biogenesis and GSK3 regulation of Myc.

• The manuscripts title implies the story is about ETC biogenesis and mitochondrial inheritance however ETC biogenesis is not directly examined and mitochondrial inheritance is only examined directly in one panel in Figure 7. The title of the manuscript should be changed to reflect the major contribution of this paper in understanding how insulin-Myc controls mitochondrial biogenesis.

Essential revisions:

\- The major focus of this study is the regulation of mitochondrial biogenesis and metabolism by the transcription factor Myc. The authors identify Myc as a regulator of SDH/COX activity based on a targeted RNAi screen. Subsequent RNAseq analysis revealed that Myc transcriptionally regulates nearly all of mitochondrial metabolism. However, a quick analysis of the RNAseq data in Supplementary File 2 reveals that 1/3 of the genome exhibit a more than 3-fold decrease in expression. The text then states that there is a significant enrichment for genes associated with mitochondrial processes, however, there is no statistical analysis supporting this claim nor is there a list of mitochondrial genes used for the analysis. Both pieces of data are required to support such a conclusion.

\- The authors use \"wt\" flies as controls for many of their experiments. Given mitochondrial function and cellular metabolism can be heavily influenced by genetic background the authors should either rescue the key phenotypes (COXIV activity, SDH activity, and mitochondrial EdU incorporation) associated with *chico* and Myc they describe in the text, or provide more suitable genetically matched controls for their key experiments.

-The authors provide a rudimentary description of the gene expression data presented in Figure 2. Given the authors belief that Myc is the key factor downstream of insulin signaling driving mitochondrial biogenesis, this data set should be analyzed in much more depth. It would also be helpful to examine how many of these Myc-regulated genes are in the mammalian data sets such as Li et al. (2005).

\- The study has major deficiencies related to the COX/SDH staining assays:

1\) To my knowledge, this is the first example of this classic assay being used in *Drosophila*. While I applaud these efforts, the authors must provide a detailed description of how they conducted the assays. For example, how long were tissues fixed? How long were tissues stained? These details are essential for evaluating the method.

2\) As described in the methods paper cited by the authors (Ross, 2011), this type of analysis requires specificity controls for both COX activity and SDH activity. Please provide this data. Note that these controls are particularly important in light of Supplementary Figure 2A, where the germarium still exhibits staining despite the use of *CoVa* RNAi.

3\) Nearly every figure contains a panel labeled \"relative ETC activity,\" yet there is no description of how this is value was calculated in the text. My best guess is that this measurement is based on the intensity of COX/SDH staining. If so, this data poses a number of problems. To conduct this type of analysis, each experiment must include a standard curve of COX activity. Moreover, each assay must also include negative controls. See (Melendez-Ferro et al., 2013) of the care that must be taken when making comparisons of COX activity across tissues samples. Based on the text included within the manuscript, I see no evidence of these controls. If the authors indeed failed to conduct these controls, this is a major issue that undermines all of the \"ETC activity\" panels.

4\) Also in regards to \"relative ETC activity,\" I\'m not sure what this term means. Do the authors mean relative combined SDH/COX activity?

5\) I\'m also concerned if total staining intensity was used as a readout. The combined COX/SDH assay produces to different colored compounds. Blue is indicative of decreased COX activity.

If the \"ETC activity\" measurements really represent intensity of COX/SDH staining, then the authors must replace these panels with some other evidence of changes in electron transport chain activity.

\- The authors make statements that imply insulin-Myc, JNK signaling have specific roles in regulating mitochondrial biogenesis, ETC biogenesis, and inheritance. However, the authors\' data suggest the observed effects on mitochondrial activity may simply reflect changes in mitochondrial biogenesis. This is a bit misleading because it implies the pathway may have a more sophisticated role in mitochondrial function than the data supports. The authors should either revise the manuscript to reflect this more simplified view or provide more clear-cut data that shows specific changes in ETC activity on a per mitochondria basis.

Similarly, the observed changes in mitochondrial inheritance could be due to defects in amplifying healthy mitochondria. Given total mitochondrial number is decreased so dramatically in *chico* and *bsk* mutant eggs, it is difficult to make strong conclusions about mitochondrial inheritance given the data presented. As a result, the authors should either revise the text to provide a more simple discussion of the data or provide evidence that examines whether the transmission of defective mitochondria in a heteroplasmic fly is under direct control of insulin-Myc signaling or simply a result of defective mitochondrial biogenesis in germ cells.

10.7554/eLife.49309.043

Author response

> Essential revisions:
>
> \- The major focus of this study is the regulation of mitochondrial biogenesis and metabolism by the transcription factor Myc. The authors identify Myc as a regulator of SDH/COX activity based on a targeted RNAi screen. Subsequent RNAseq analysis revealed that Myc transcriptionally regulates nearly all of mitochondrial metabolism. However, a quick analysis of the RNAseq data in Supplementary File 2 reveals that 1/3 of the genome exhibit a more than 3-fold decrease in expression. The text then states that there is a significant enrichment for genes associated with mitochondrial processes, however, there is no statistical analysis supporting this claim nor is there a list of mitochondrial genes used for the analysis. Both pieces of data are required to support such a conclusion.

We previously published the list of nuclear-encoded mitochondrial genes in the *Drosophila* genome (Zhang et al., 2019). We used this list as the reference to evaluate the significant enrichment of genes associated with mitochondrial processes in the context of genes affected in *myc* mutant ovaries, and carried out a gene ontology analysis for the enrichment of cellular pathways. The detailed procedure of the bioinformatic analysis has been included in the revised Materials and methods section. We now include the list of genes and the statistical analyses in the Supplementary Files 3-5, and describe the procedure and result of the cellular pathway enrichment analysis in the Materials and methods.

> \- The authors use \"wt\" flies as controls for many of their experiments. Given mitochondrial function and cellular metabolism can be heavily influenced by genetic background the authors should either rescue the key phenotypes (COXIV activity, SDH activity, and mitochondrial EdU incorporation) associated with chico and Myc they describe in the text, or provide more suitable genetically matched controls for their key experiments.

The *chico* and *myc* mutants have been backcrossed to *w^1118^*to clean up the genetic background, and *w^1118^*flies were used as the control in these experiments. We clarify this issue in the revised Materials and methods section.

> -The authors provide a rudimentary description of the gene expression data presented in Figure 2. Given the authors belief that Myc is the key factor downstream of insulin signaling driving mitochondrial biogenesis, this data set should be analyzed in much more depth. It would also be helpful to examine how many of these Myc-regulated genes are in the mammalian data sets such as Li et al. (2005).

As we addressed a previous comment on the RNAseq data analysis, we have re-analyzed RNAseq data and include the detailed analyses in the Supplementary File 3.

In the previous study (Li et al., 2005), a total of 2679 genes were reported to be regulated by Myc in a human cell line. However, only 198 mitochondrial genes emerged from this study, presumably due to the lack of a full compendium of mitochondrial genes (MitoCarta) back then. Also, the full list of Myc-regulated genes is not available from that study (Li et al., 2005), which prevents us from carrying out further analyses with the mammalian data set. Nonetheless, we looked into the 198 Myc-regulated mitochondrial genes, and found that 185 of them have homologs in *Drosophila*. Importantly, 44.9% (101 out of 225) of the fly homologs are down-regulated in *myc^P0^*mutant ovaries. This analysis indeed demonstrates an evolutionarily conserved function of Myc in regulating mitochondrial biogenesis. We discuss this comparative analysis in the second paragraph of the Discussion, and include the dataset in the Supplementary File 6.

> \- The study has major deficiencies related to the COX/SDH staining assays:
>
> 1\) To my knowledge, this is the first example of this classic assay being used in Drosophila. While I applaud these efforts, the authors must provide a detailed description of how they conducted the assays. For example, how long were tissues fixed? How long were tissues stained? These details are essential for evaluating the method.

We now describe the experimental procedure in detail in the Materials and methods subsection "SDH and COX activity staining in the ovary".

> 2\) As described in the methods paper cited by the authors (Ross, 2011), this type of analysis requires specificity controls for both COX activity and SDH activity. Please provide this data. Note that these controls are particularly important in light of Supplementary Figure 2A, where the germarium still exhibits staining despite the use of CoVa RNAi.

Complex IV (COX, brown staining) is disrupted by *CoVa* RNAi, while complex II remains intact. Thus, the staining in the germarium of *CoVa* RNAi is predominantly derived from the SDH activity (blue color). We have moved these data to the revised Figure 1---figure supplement 1C.

> 3\) Nearly every figure contains a panel labeled \"relative ETC activity,\" yet there is no description of how this is value was calculated in the text. My best guess is that this measurement is based on the intensity of COX/SDH staining. If so, this data poses a number of problems. To conduct this type of analysis, each experiment must include a standard curve of COX activity. Moreover, each assay must also include negative controls. See (Melendez-Ferro et al., 2013) of the care that must be taken when making comparisons of COX activity across tissues samples. Based on the text included within the manuscript, I see no evidence of these controls. If the authors indeed failed to conduct these controls, this is a major issue that undermines all of the \"ETC activity\" panels.
>
> 4\) Also in regards to \"relative ETC activity,\" I\'m not sure what this term means. Do the authors mean relative combined SDH/COX activity?
>
> 5\) I\'m also concerned if total staining intensity was used as a readout. The combined COX/SDH assay produces to different colored compounds. Blue is indicative of decreased COX activity.
>
> If the \"ETC activity\" measurements really represent intensity of COX/SDH staining, then the authors must replace these panels with some other evidence of changes in electron transport chain activity.

We agree with the reviewers that the combined COX/SDH assay is best suited for quantification, even though we noticed that the majority of color deposit was derived from COX activity stanning in the COX/SDH dual staining assay. In the revision, we carried out COX staining along, and used the COX activity as an indication of ETC activity.

We applied the KCN, the inhibitor of COX in the experiments to confirm the specificity of COX activity staining. We also generated the standard curve of COX, adopting the procedure used in the paper suggested by the reviewer. The optical density of COX activity staining fits a linear relationship with the amount of cytochrome C oxidase (Sigma) used in the assay. We therefore used OD as a means to semi-quantify the relative SDH or COX activity. We revised the figure to include the new data, and describe the experimental procedure in the Materials and methods section.

> \- The authors make statements that imply insulin-Myc, JNK signaling have specific roles in regulating mitochondrial biogenesis, ETC biogenesis, and inheritance. However, the authors' data suggest the observed effects on mitochondrial activity may simply reflect changes in mitochondrial biogenesis. This is a bit misleading because it implies the pathway may have a more sophisticated role in mitochondrial function than the data supports. The authors should either revise the manuscript to reflect this more simplified view or provide more clear-cut data that shows specific changes in ETC activity on a per mitochondria basis.
>
> Similarly, the observed changes in mitochondrial inheritance could be due to defects in amplifying healthy mitochondria. Given total mitochondrial number is decreased so dramatically in chico and bsk mutant eggs, it is difficult to make strong conclusions about mitochondrial inheritance given the data presented. As a result, the authors should either revise the text to provide a more simple discussion of the data or provide evidence that examines whether the transmission of defective mitochondria in a heteroplasmic fly is under direct control of insulin-myc signaling or simply a result of defective mitochondrial biogenesis in germ cells.

Previous studies demonstrate that the prodigious mitochondrial biogenesis during oogenesis not only furnishes mature oocytes with adequate amount of mitochondria, but also allows proliferation competition, which limits the transmission of deleterious mtDNA mutations (Zhang et al., 2019).

We revised the manuscript to reflect that insulin-Myc signaling primarily promotes mitochondrial biogenesis, through which it can influence mitochondrial inheritance both quantitively and quantitively. It now reads "This signaling relay promotes mitochondrial biogenesis in the ovary, and thereby plays a role in limiting the transmission of deleterious mtDNA mutations.".
